Dermatology Drugs Market - Industry Trends andt
Dermatology Drugs Market - Industry Trends and Forecast to 2026 with key
market like Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi,
GlaxoSmithKline plc, Amgen inc., Eli Lilly and Company, AstraZeneca, AbbVie Inc.
Dermatology
Drugs Market By Dermatological Diseases (Acne, Dermatitis, Psoriasis, Skin
Cancer and Others); Prescription mode (Prescription Based Drugs, Over
Counter Drugs); Drug Classification (Corticosteroids, Astringents,
Anti-Inflammatory & Antipruritic Drugs, Anti-Infective/Antibacterial Drugs,
Antifungal Drugs), Route Of Administration (Topical, Oral, Parenteral
Administration), Distribution Channel (Hospital Pharmacies, Retail Pharmacies,
Online Pharmacies); End User (Hospitals, Speciality Clinics, Cosmetic Centres)
Geography (North America, South America, Europe, Asia-Pacific, Middle East and
Africa) - Industry Trends and Forecast to 2026
Market Analysis: Global Dermatology Drugs
Market
Global Dermatology Drugs
Market is expected to rise from its initial estimated value of USD 24.4 billion
in 2018 to an estimated value of USD 51.7 billion by 2026 registering a CAGR of
9.8%. The upcoming market report contains data for historic year 2017, 2016,
the base year of calculation is 2018 and the forecast period is 2021 to 2026.
Download full sample report of Dermatology
Drugs Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-dermatology-drugs-market
Market Definition:
Global Dermatology Drugs Market
A dermatology drugs are
used in the management and treatment of diseases related to skin, nail, hair,
and genital membranes. The skin is the largest organ in the
body. The growing concern towards skin disease is driving factor of the
industry.
Market Drivers
Growing number of skin diseases across all age-groups.
Rising expenditure on personal care.
Awareness towards skin disease & Hail issues increased.
Market Restraint
Stringent regulations for dermatology drugs approval
Segmentation: Global
Dermatology Drugs Market
By Diseases
·
Acne
·
Dermatitis
·
Psoriasis
·
Skin
cancer
·
Others
By Prescription mode
·
prescription
based drugs
·
Counter
drugs
By Drug Classification
·
Corticosteroids
·
Astringents
·
Anti-inflammatory
·
Antipruritic
drugs
·
Anti-infective/antibacterial
drugs
·
Antifungal
drugs
By Route of Administration
·
Topical
·
Oral
·
Parenteral
administration
By Distribution channels
·
Hospital
pharmacies
·
Retail
pharmacies
·
Online
pharmacies.
By End-Users
·
Hospitals
·
Specialty
clinics
·
Cosmetic
centers
By Geography
·
North
America
·
US.
·
Canada
·
Mexico
·
South
America
·
Brazil
·
Argentina
·
Rest
of South America
·
Europe
·
Germany
·
France
·
United
Kingdom
·
Italy
·
Spain
·
Russia
·
Turkey
·
Belgium
·
Netherlands
·
Switzerland
·
Rest
of Europe
·
Asia-Pacific
·
Japan
·
China
·
South
Korea
·
India
·
Australia
·
Singapore
·
Malaysia
·
Indonesia
·
Thailand
·
Philippines
·
Rest
of Asia-Pacific
·
Middle
East and Africa
·
South
Africa
·
Egypt
·
Saudi
Arabia
·
United
Arab Emirates
·
Israel
·
Rest
of Middle East and Africa
Key Developments in the Market:
In April, 2021, LEO Pharma announced expansion of its existing
partnership with Elektrofi for development of more convenient system for
dermatology treatments. This will reduce time required to conduct the
treatment.
In August 2018, Lupin Ltd a drug maker firm Enters in the Brazil
market. They entered in Prescription Dermatology segment with two new developed
products. The Brazil is Growing market for Dermatology Drugs.
Competitive Analysis:
Global Dermatology Drugs Market
The global
dermatology drugs market is highly fragmented and the major players have
used various strategies such as new product launches, expansions, agreements,
joint ventures, partnerships, acquisitions and others to increase their
footprints in this market. The report includes market shares of Dermatology
Drugs market for Global, Europe, North America, Asia Pacific, South America and
Middle East & Africa.
Key Market Competitors:
Global Dermatology Drugs Market
Some of the major
players of the global Dermatology Drugs market are LUPIN, Novartis AG, F.
Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi, GlaxoSmithKline plc, Amgen inc.,
Eli Lilly and Company, AstraZeneca, AbbVie Inc, Johnson & Johnson
Services.Inc, Galderma laboratories L.P. , LEO Pharma A/S, Merck & Co.,Inc,
Bausch Health, Bristol-Myers Squibb Company, among others.
Get full details of TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-dermatology-drugs-market
Reasons
for Buying this Report
This
report provides pin-point analysis for changing competitive dynamics
It
provides a forward looking perspective on different factors driving or
restraining market growth
It
provides a six-year forecast assessed on the basis of how the market is predicted
to grow
It helps
in understanding the key product segments and their future
It
provides pin point analysis of changing competition dynamics and keeps you
ahead of competitors
It helps
in making informed business decisions by having complete insights of market and
by making in-depth analysis of market segments
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-dermatology-drugs-market
About
Us:
Data
Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting
firm with unparalleled level of resilience and integrated approaches. We are
determined to unearth the best market opportunities and foster efficient
information for your business to thrive in the market
Contact:
Tel:
+1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse
Related Reports @
Pediatric Heart Failure Market
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
